Ronit Berger serves as the Immuno-Oncology Brand Lead at Bristol Myers Squibb since June 2018, overseeing thoracic and GU malignancies and acting as the South East Asia Oncology Advisor. In previous roles, Ronit led commercial activities for top-selling immuno-oncology assets Opdivo and Yervoy while contributing to the company's business strategy. Additionally, Ronit has been involved with the Woman Executive Launchpad initiative at WE@HealthTech since April 2022 and worked as a Product Specialist in the Oncotest Diagnostic Division at Teva Pharmaceuticals from September 2006 until June 2018. Educational qualifications include a Bachelor's degree in Social Welfare and Health Sciences from the University of Haifa and ongoing studies at Reichman University.